Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

762881

Sigma-Aldrich

Poly(N-isopropylacrylamide-co-butylacrylate)

butylacrylate 12 mol %, average Mn 30,000

Synonym(s):

NIPAM, polyNIPAM, polyNIPAM-BA

Sign Into View Organizational & Contract Pricing

Select a Size

5 G
€457.00

€457.00

Please contact Customer Service for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
5 G
€457.00

About This Item

Linear Formula:
(C6H11NO)m(C7H12O2)n
UNSPSC Code:
12162002
NACRES:
NA.23

€457.00

Please contact Customer Service for Availability
Request a Bulk Order

form

solid

feed ratio

NIPAM:BA 8:1

mol wt

average Mn 30,000

composition

butylacrylate, 12 mol %

transition temp

LCST 14-16 °C

PDI

1.51

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Random copolymer of N-isopropylacrylamide with 12 mole % butylacrylate. This copolymer shows LCST at 15 C (lower temperature than PolyNIPAM).

Application

Thermosensitive polymer; can be used to form a hydrogel. Aqueous polymer solution undergoes a phase transition from a soluble to an insoluble state when the temperature is raised to ca. 15 °C.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCH6033
MKBK9957

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Stimuli-Responsive Materials as Intelligent Drug Delivery Systems

By altering the physicochemical properties, smart or intelligent drug delivery systems can be designed to deliver therapeutic molecules on-demand. Learn more about the application of stimuli-responsive materials in drug delivery.

Therapeutic Nanoparticles Harness Myeloid Cells for Brain Tumor-Targeted Delivery and Immunomodulation

Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service